LB Pharmaceuticals Inc Common Stock (LBRX) NASDAQ
24.93
+0.265(+1.07%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 563.16M |
| Enterprise Value | 316.56M |
| P/E Ratio | -25.3 |
| PEG Ratio | -57.9 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.12 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -14.13 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -0.08 |
| Return On Equity | -0.19 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -321,000 |
| EBITDA | -30.08M |
| Net Income | -25.21M |
| Diluted EPS | -1 |
Balance Sheet
| Total Cash | 295.21M |
| Total Cash/Share | 11.67 |
| Total Debt | 3.57M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 41.44 |
| Book Value Per Share | 11.91 |
Price History
| 52-Week Change | 45.72 |
| 52-Week High | 27.55 |
| 52-Week Low | 13.36 |
| Moving Average 50 Days | 23.68 |
| Moving Average 200 Days | 19.76 |
Statistics
| Average Volume | 229,501 |
| Shares Outstanding | 25.3M |
| % Held by Institutions | 97.99 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
